Product Images Doxycycline Hyclate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Doxycycline Hyclate NDC 68382-709 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Doxycycline hyclate - 06f46338 f5cf 446f b88b d3a59290175f 01

Doxycycline hyclate - 06f46338 f5cf 446f b88b d3a59290175f 01

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 02

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 02

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 03

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 03

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 04

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 04

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 05

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 05

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 06

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 06

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 07

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 07

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 08

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 08

This is a medication package for Doxycycline Hyclate Delayed-Release tablets, USP. Each tablet contains specially coated pellets of doxycycline hyclate equivalent to 75 mg of doxycycline. The usual dosage should be checked from the package insert or full prescribing information. The tablets should not be chewed or crushed. Store at a temperature of 20° to 25° C (68 to 77° F) with permissible excursions of 15° to 30°C (59° to 86°F). The medication should be dispensed in a light and airtight resistant container. This drug should be kept out of reach of children. Manufactured by Catal Healthcare Ltd in Ahmedabag, India, and distributed by Zydus Pharmaceuticals (USA) Inc in New Jersey.*

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 09

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 09

This is a description of medication called Doxycycline Hyclate. It comes in the form of pellets and delayed-release tablets, with 100 mg of doxycycline equivalent. The usual dosage is recommended in the package insert. It should be stored at temperatures between 20°-25° C, dispersed inside a tight container. The medication should be kept out of children's reach. These tablets are not recommended to be chewed or crushed. This medication is distributed by Zydus in Penrington, NJ, USA.*

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 10

Doxycycline Hyclate Delayed-release Tablets - 06f46338 f5cf 446f b88b d3a59290175f 10

This is a description of Doxycycline Hyclate Delayed-Release Tablets, USP containing 150mg specially coated pellets of doxycycline hyclate. The tablets should not be chewed or crushed and usual dosage should be seen on the package insert. They should be stored at 20°-25° C and kept in a tight, light-resistant container out of reach of children. Manufactured by Casla Healthare Ltd in Anmedabad, India and distributed by Zydus Pharmaceuticals (USA) Inc in Pennington, NJ 08534.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.